PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,677,550 | -30.0% | 208,726 | +27.1% | 0.00% | -50.0% |
| Q2 2023 | $6,677,893 | -44.7% | 164,197 | -34.1% | 0.00% | -33.3% |
| Q1 2023 | $12,065,144 | +43.1% | 249,074 | +12.8% | 0.00% | +50.0% |
| Q4 2022 | $8,428,738 | +66.8% | 220,821 | +119.3% | 0.00% | 0.0% |
| Q3 2022 | $5,053,000 | -46.8% | 100,671 | -57.5% | 0.00% | -33.3% |
| Q2 2022 | $9,499,000 | +444.4% | 237,119 | +407.2% | 0.00% | – |
| Q1 2022 | $1,745,000 | +2.5% | 46,749 | +9.4% | 0.00% | – |
| Q4 2021 | $1,702,000 | +1.7% | 42,749 | -4.9% | 0.00% | – |
| Q3 2021 | $1,674,000 | -0.1% | 44,970 | +13.5% | 0.00% | – |
| Q2 2021 | $1,675,000 | +23.8% | 39,623 | +38.6% | 0.00% | – |
| Q1 2021 | $1,353,000 | +11.8% | 28,582 | +44.2% | 0.00% | – |
| Q4 2020 | $1,210,000 | +125.3% | 19,826 | +72.4% | 0.00% | – |
| Q3 2020 | $537,000 | -8.4% | 11,502 | -0.5% | 0.00% | – |
| Q2 2020 | $586,000 | -90.0% | 11,554 | -91.2% | 0.00% | -100.0% |
| Q1 2020 | $5,887,000 | +1944.1% | 131,961 | +2101.9% | 0.00% | – |
| Q4 2019 | $288,000 | +34.0% | 5,993 | -5.8% | 0.00% | – |
| Q3 2019 | $215,000 | -26.9% | 6,360 | -2.8% | 0.00% | – |
| Q2 2019 | $294,000 | -96.9% | 6,540 | -97.4% | 0.00% | -100.0% |
| Q1 2019 | $9,488,000 | +26.4% | 252,079 | +15.3% | 0.00% | 0.0% |
| Q4 2018 | $7,505,000 | -27.9% | 218,686 | -1.2% | 0.00% | 0.0% |
| Q3 2018 | $10,403,000 | -31.4% | 221,332 | -50.8% | 0.00% | -40.0% |
| Q2 2018 | $15,164,000 | +479.0% | 449,584 | +186.3% | 0.01% | +400.0% |
| Q4 2017 | $2,619,000 | -48.6% | 157,017 | -38.3% | 0.00% | -50.0% |
| Q3 2017 | $5,092,000 | +1481.4% | 254,458 | +1347.6% | 0.00% | – |
| Q2 2017 | $322,000 | +84.0% | 17,578 | -1.2% | 0.00% | – |
| Q1 2017 | $175,000 | -81.8% | 17,798 | -79.8% | 0.00% | – |
| Q4 2016 | $964,000 | -36.2% | 88,321 | +56.2% | 0.00% | -100.0% |
| Q3 2015 | $1,510,000 | +30100.0% | 56,527 | +53735.2% | 0.00% | – |
| Q2 2015 | $5,000 | -99.9% | 105 | -99.9% | 0.00% | -100.0% |
| Q1 2015 | $5,666,000 | +9.3% | 93,116 | -7.0% | 0.00% | 0.0% |
| Q4 2014 | $5,184,000 | +4.0% | 100,123 | -11.6% | 0.00% | 0.0% |
| Q3 2014 | $4,984,000 | +139.6% | 113,246 | +42.3% | 0.00% | +100.0% |
| Q2 2014 | $2,080,000 | +2.6% | 79,583 | +2.6% | 0.00% | 0.0% |
| Q1 2014 | $2,027,000 | +53.6% | 77,562 | -0.3% | 0.00% | 0.0% |
| Q4 2013 | $1,320,000 | +18.9% | 77,813 | +50.4% | 0.00% | – |
| Q3 2013 | $1,110,000 | – | 51,739 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |